Table 5

Table showing frailty and quality of life scores in patients who attended both a baseline as well as a follow-up assessment (n=103)

n=103Baseline assessmentFollow-upP value
Clinical characteristicsAge83.6±3.0 (83.0–84.1)
Female33 (32.0%)
BMI27.3±4.0 (26.5–28.1)
h/o Hypertension64 (62.1%)
h/o Diabetes25 (24.8%)
h/o Previous MI46 (44.7%)
h/o CKD
Creat clearance >857 (6.8%)
Creat clearance 50–8545 (43.7%)
Creat clearance <5050 (48.5%)
Coronary angiography (n=59)Single-vessel disease12 (20.3%)
Two-vessel disease24 (40.7%)
Three-vessel disease23 (39.0%)
LV function (n=79)LVEF ≥5543 (54.4%)
LVEF 46%–54%18 (22.8%)
LVEF 36%–45%13 (16.5%)
Severe LVEF ≤35%5 (6.3%)
CCS angina classNo chest pain7 (6.8%)61 (59.2%)<0.001
CCS class I15 (14.6%)17 (16.5%)
CCS class II33 (32.0%)20 (19.4%)
CCS class III32 (31.1%)5 (4.9%)
CCS class IV16 (15.5%)0 (0.0%)
NYHA classNYHA class I6 (5.8%)17 (16.5%)0.05
NYHA class II64 (62.1%)55 (53.4%)
NYHA class III29 (28.2%)27 (26.2%)
NYHA class IV4 (3.9%)4 (3.9%)
Fried frailty phenotypeNot frail13 (12.6%)19 (18.5%)0.56
Pre-frail62 (60.2%)54 (52.4%)
Frail28 (27.2%)30 (29.1%)
Edmonton frailty scoreNot frail60 (58.3%)60 (58.3%)0.66
Vulnerable17 (16.5%)19 (18.4%)
Mild frailty15 (14.6%)16 (15.5%)
Moderate frailty8 (7.8%)4 (3.9%)
Severe frailty3 (2.9%)4 (3.9%)
SF-12 physical composite score37.2±11.038.5±11.30.27
Physical health composite scoreAt or above27 (26.2%)33 (32.0%)0.19
Below13 (12.6%)13 (12.6%)
Far below63 (61.2%)56 (54.4%)
SF-12 mental composite score52.7±11.555.1±10.60.04
Mental health composite scoreAt or above81 (78.6%)84 (81.6%)0.19
Below4 (3.9%)7 (6.8%)
Far below18 (17.5%)11 (10.7%)
  • BMI, body mass index; CCS, Canadian Cardiovascular Society; CKD, chronic kidney disease; h/o, history of; LVEF, left ventricle ejection fraction; MI, myocardial infarction; NYHA, New York Heart Association.